These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23085381)

  • 1. What have we learnt about high-density lipoprotein cholesterol measurements during 32 years? Experiences in Finland 1980-2012.
    Leiviskä J; Sundvall J; Alfthan G; Tähtelä R; Salomaa V; Jauhiainen M; Vartiainen E
    Clin Chim Acta; 2013 Jan; 415():118-23. PubMed ID: 23085381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference.
    Juonala M; Viikari JS; Hutri-Kähönen N; Pietikäinen M; Jokinen E; Taittonen L; Marniemi J; Rönnemaa T; Raitakari OT
    J Intern Med; 2004 Apr; 255(4):457-68. PubMed ID: 15049880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
    Laitinen DL; Manthena S
    Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.
    Söderlund S; Watanabe H; Ehnholm C; Jauhiainen M; Taskinen MR
    Metabolism; 2010 Oct; 59(10):1502-9. PubMed ID: 20206948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
    Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
    Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.
    Olson EJ; Pearce GL; Jones NP; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2289-94. PubMed ID: 22814748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of low HDL cholesterol, and relationship between serum HDL and cardiovascular disease in elderly Spanish population: the PREV-ICTUS study.
    Cea-Calvo L; Lozano JV; Fernández-Pérez C; Llisterri JL; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Int J Clin Pract; 2009 Jan; 63(1):71-81. PubMed ID: 19125995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome prevalence, dietary intake, and cardiovascular risk profile among overweight and obese adults 18-50 years old from the United Arab Emirates.
    Al-Sarraj T; Saadi H; Volek JS; Fernandez ML
    Metab Syndr Relat Disord; 2010 Feb; 8(1):39-46. PubMed ID: 19929603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
    HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease.
    Chen GL; Liu LW; Xie S; Liu H; Liu YQ; Li YS
    Chin Med J (Engl); 2010 Mar; 123(6):658-63. PubMed ID: 20368082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Olijhoek JK; Visseren FL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):870-7. PubMed ID: 18394022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.
    Corsetti JP; Gansevoort RT; Bakker SJ; Navis G; Sparks CE; Dullaart RP
    Metabolism; 2012 Jul; 61(7):996-1002. PubMed ID: 22225956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HDL-C concentration and risk for a major cardiovascular event.
    Laitinen DL; Manthena S; Webb S
    Curr Med Res Opin; 2010 Apr; 26(4):933-41. PubMed ID: 20163298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.